Notably, IL-6/STAT3 signaling can induce a cancer stem cell phenotype: IL-6 drives the expansion of breast cancer stem-like cells by upregulating stemness factors and maintaining an undifferentiated, therapy-resistant state. This evidence concerns the gene STAT3 and breast carcinoma.